Related references
Note: Only part of the references are listed.Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19(Arf)/p53 pathway lesions but not p16(Ink4a) loss
Michael T. Debies et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Christopher J. Sarkisian et al.
NATURE CELL BIOLOGY (2007)
Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis
Joanne W. Jang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The transcriptional repressor snail promotes mammary tumor recurrence
SE Moody et al.
CANCER CELL (2005)
Suppression of p53 by Notch in lymphomagenesis: Implications for initiation and regression
LJ Beverly et al.
CANCER RESEARCH (2005)
Oncogene-induced senescence as an initial barrier in lymphoma development
M Braig et al.
NATURE (2005)
Tyrosine kinases as targets for cancer therapy
DS Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Rehabilitation of cancer through oncogene inactivation
CM Shachaf et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
Antiapoptotic BCL-2 is required for maintenance of a model leukemia
A Letai et al.
CANCER CELL (2004)
Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation
RB Boxer et al.
CANCER CELL (2004)
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient
E Tamborini et al.
GASTROENTEROLOGY (2004)
Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation
T Wakai et al.
BRITISH JOURNAL OF CANCER (2004)
Developmental context determines latency of MYC-induced tumorigenesis
S Beer et al.
PLOS BIOLOGY (2004)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
CM Shachaf et al.
NATURE (2004)
Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype
Katrina Podsypanina et al.
BMC MEDICINE (2004)
Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis
Stella Pelengaris et al.
BMC BIOLOGY (2004)
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells
Y Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
M Jain et al.
SCIENCE (2002)
A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology
EJ Gunther et al.
FASEB JOURNAL (2002)
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
GH Fisher et al.
GENES & DEVELOPMENT (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations
CM D'Cruz et al.
NATURE MEDICINE (2001)
Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity
S Urlinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
